# GBank Financial Holdings Inc.: financial statements, quarterly

GBFH · Nasdaq · CIK 1791145 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gbfh.md) · [Financials](/companies/gbfh/financials.md) · [Filings](/companies/gbfh/filings.md) · [Insiders](/companies/gbfh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gbfh/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [1,112](/filings/0000950170-25-078361.md) | [1,411](/filings/0000950170-25-107361.md) | [1,513](/filings/0001193125-25-276230.md) | [1,239 d](/filings/0001193125-26-129567.md) | [1,224](/filings/0001193125-26-226363.md) | [1,486](/filings/0001193125-26-349269.md) | [1,282](/filings/0001193125-25-276230.md) | [2,027 d](/filings/0001193125-26-129567.md) | [139](/filings/0001193125-26-226363.md) | [1,625](/filings/0001193125-26-349269.md) |
| Net income | $k | [3,701](/filings/0001193125-25-276230.md) | [4,676](/filings/0001193125-25-276230.md) | [5,015](/filings/0001193125-25-276230.md) | [5,244 d](/filings/0001193125-26-129567.md) | [4,470](/filings/0001193125-26-349269.md) | [4,755](/filings/0001193125-26-349269.md) | [4,308](/filings/0001193125-25-276230.md) | [7,396 d](/filings/0001193125-26-129567.md) | [1,315](/filings/0001193125-26-349269.md) | [5,462](/filings/0001193125-26-349269.md) |
| Diluted EPS | $ per share | [0.29](/filings/0000950170-25-078361.md) | [0.36](/filings/0000950170-25-107361.md) | [0.38](/filings/0001193125-25-276230.md) | not reported | [0.31](/filings/0001193125-26-226363.md) | [0.33](/filings/0001193125-26-349269.md) | [0.30](/filings/0001193125-25-276230.md) | not reported | [0.09](/filings/0001193125-26-226363.md) | [0.38](/filings/0001193125-26-349269.md) |
| Basic EPS | $ per share | [0.29](/filings/0000950170-25-078361.md) | [0.36](/filings/0000950170-25-107361.md) | [0.38](/filings/0001193125-25-276230.md) | not reported | [0.31](/filings/0001193125-26-226363.md) | [0.33](/filings/0001193125-26-349269.md) | [0.30](/filings/0001193125-25-276230.md) | not reported | [0.09](/filings/0001193125-26-226363.md) | [0.38](/filings/0001193125-26-349269.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | not reported | [963](/filings/0000950170-25-078361.md) | [1,009](/filings/0000950170-25-107361.md) | [1,048](/filings/0001193125-25-276230.md) | [1,122](/filings/0001193125-26-129567.md) | [1,190](/filings/0001193125-26-226363.md) | [1,232](/filings/0001193125-26-349269.md) | [1,301](/filings/0001193125-25-276230.md) | [1,359](/filings/0001193125-26-349269.md) | [1,394](/filings/0001193125-26-226363.md) | [1,432](/filings/0001193125-26-349269.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [982](/filings/0001193125-26-129567.md) | [1,043](/filings/0000950170-25-078361.md) | [1,081](/filings/0000950170-25-107361.md) | [1,143](/filings/0001193125-25-276230.md) | [1,194](/filings/0001193125-26-349269.md) | [1,226](/filings/0001193125-26-226363.md) | [1,259](/filings/0001193125-26-349269.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-129567.md) | not reported | not reported | not reported | [0.4](/filings/0001193125-26-349269.md) | [0.0](/filings/0001193125-26-226363.md) | [0.0](/filings/0001193125-26-349269.md) |
| Shareholders' equity | $m | [98.4](/filings/0001193125-26-129567.md) | [103](/filings/0001193125-25-276230.md) | [111](/filings/0001193125-25-276230.md) | [116](/filings/0001193125-25-276230.md) | [141](/filings/0001193125-26-349269.md) | [147](/filings/0001193125-26-349269.md) | [152](/filings/0001193125-26-349269.md) | [158](/filings/0001193125-25-276230.md) | [166](/filings/0001193125-26-349269.md) | [168](/filings/0001193125-26-349269.md) | [173](/filings/0001193125-26-349269.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.8)](/filings/0000950170-25-078361.md) | [8.4 d](/filings/0000950170-25-107361.md) | [(13.8) d](/filings/0001193125-25-276230.md) | [39.6 d](/filings/0001193125-26-129567.md) | [(5.7)](/filings/0001193125-26-226363.md) | [0.9 d](/filings/0001193125-26-349269.md) | [(12.2) d](/filings/0001193125-25-276230.md) | [26.7 d](/filings/0001193125-26-129567.md) | [(10.1)](/filings/0001193125-26-226363.md) | [27.5 d](/filings/0001193125-26-349269.md) |
| Capital expenditure | $m | [0.0](/filings/0000950170-25-078361.md) | [0.0 d](/filings/0000950170-25-107361.md) | [0.1 d](/filings/0001193125-25-276230.md) | [0.0 d](/filings/0001193125-26-129567.md) | [0.0](/filings/0001193125-26-226363.md) | [0.0 d](/filings/0001193125-26-349269.md) | [0.1 d](/filings/0001193125-25-276230.md) | [0.3 d](/filings/0001193125-26-129567.md) | [0.2](/filings/0001193125-26-226363.md) | [0.2 d](/filings/0001193125-26-349269.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.9](/filings/0000950170-25-078361.md) | [13.0](/filings/0000950170-25-107361.md) | [13.2](/filings/0001193125-25-276230.md) | [14.5](/filings/0001193125-26-226363.md) | [14.6](/filings/0001193125-26-349269.md) | [14.5](/filings/0001193125-25-276230.md) | [14.5](/filings/0001193125-26-226363.md) | [14.5](/filings/0001193125-26-349269.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,516,457 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349269.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.